These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
440 related items for PubMed ID: 23337211
1. Cost-effectiveness analysis: stress ulcer bleeding prophylaxis with proton pump inhibitors, H2 receptor antagonists. Barkun AN, Adam V, Martel M, Bardou M. Value Health; 2013; 16(1):14-22. PubMed ID: 23337211 [Abstract] [Full Text] [Related]
2. Cost-Effectiveness of Histamine2 Receptor Antagonists Versus Proton Pump Inhibitors for Stress Ulcer Prophylaxis in Critically Ill Patients. Hammond DA, Kathe N, Shah A, Martin BC. Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338 [Abstract] [Full Text] [Related]
12. Gastroprotective strategies in chronic NSAID users: a cost-effectiveness analysis comparing single-tablet formulations with individual components. de Groot NL, Spiegel BM, van Haalen HG, de Wit NJ, Siersema PD, van Oijen MG. Value Health; 2013 Jun; 16(5):769-77. PubMed ID: 23947970 [Abstract] [Full Text] [Related]
13. [Bleeding and pneumonia in intensive care unit patients given proton pump inhibitor or histamine-2 receptor antagonist for prevention of stress ulcer: a Meta analysis]. Zhou JF, Wan XY, Huang W, Han LL. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Apr; 22(4):221-5. PubMed ID: 20398466 [Abstract] [Full Text] [Related]
14. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs. Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519 [Abstract] [Full Text] [Related]
15. Pneumonia prevention in intubated patients given sucralfate versus proton-pump inhibitors and/or histamine II receptor blockers. Grindlinger GA, Cairo SB, Duperre CB. J Surg Res; 2016 Dec; 206(2):398-404. PubMed ID: 27884335 [Abstract] [Full Text] [Related]
19. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. MacLaren R, Reynolds PM, Allen RR. JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015 [Abstract] [Full Text] [Related]
20. Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada. Tett SE, Sketris I, Cooke C, van Zanten SV, Barozzi N. Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):735-43. PubMed ID: 23559528 [Abstract] [Full Text] [Related] Page: [Next] [New Search]